Daniel Schryer
Angel Investor
Daniel Schryer is a seed investor focused on Software and Internet. Dan Schryer was formerly CEO of DCI Data Centers, a Blackstone backed technology real estate company. Together with Guru Gowrappan, formerly CEO of Verizon Media, he co-founded Bali Venture Partners, LLC to invest in seed and growth stage debt and equity opportunities.
- Total investments:
- 36
- Last investment:
- Lead investor:
- 3%
Last updated:
For AI agents: llms.txt
Industries Daniel Schryer invests in
Stages Daniel Schryer invests in
Countries Daniel Schryer invests in
Round sizes
Round size
- Seed
- $25k–$1M
- Angel
- $75k–$670k
- Series B
- $150k–$50M
Investment Focus
Industry
- Software 7 (19%)
- Internet 6 (17%)
- Mobile 4 (11%)
- FinTech 4 (11%)
- E-Commerce 4 (11%)
Stage
- Seed 10 (28%)
- Series B 4 (11%)
- Angel 3 (8%)
- Series A 3 (8%)
- Pre-Seed 2 (6%)
Country
- United States 22 (61%)
- India 2 (6%)
- Panama 1 (3%)
- Sweden 1 (3%)
- Hong Kong 1 (3%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
54gene
|
54gene is a healthcare startup unlocking the African genome to fuel genetic research and development that may lead to new discoveries and benefit all populations.54gene was founded in 2019 by Dr. Abasi Ene-Obong to address the significant gap in the global genomics market: Nearly 90% of genetic material used in pharmaceutical research iscaucasian. Only 2% is African, despite the fact that Africans and people of African ancestry are more genetically diverse than all other world populations combined. As a result, pharmaceutical research and development is lacking the diverse data that may hold the key to medical discoveries and new healthcare solutions. | $75K / Jul 23, 2021 | |
|
54gene
|
54gene is a healthcare startup unlocking the African genome to fuel genetic research and development that may lead to new discoveries and benefit all populations.54gene was founded in 2019 by Dr. Abasi Ene-Obong to address the significant gap in the global genomics market: Nearly 90% of genetic material used in pharmaceutical research iscaucasian. Only 2% is African, despite the fact that Africans and people of African ancestry are more genetically diverse than all other world populations combined. As a result, pharmaceutical research and development is lacking the diverse data that may hold the key to medical discoveries and new healthcare solutions. | $75K / Angel / Jul 23, 2021 | |
SOS Hydration
|
SOS Hydration is a manufacturer of hydration drink mixes designed to combat dehydration. The company provides an electrolyte replacement and hydration drink that aids in the prevention of dehydration caused by an active lifestyle and strenuous physical activities. SOS was founded by two brothers who were both elite athletes and medical doctors. | $300K / Convertible Note / Jun 17, 2021 | |
Betterhalf
|
Uniquely positioned as a new age matrimony platform, Betterhalf envisions to build a super app of Indian matrimony and full stack wedding services as company's growth pillars. Founded by Pawan Gupta and Rahul Namdev, Betterhalf recently raised Series A backed by FinSight Ventures (Ex Bumble investor) & other marquee investors includingMike Krieger, Co-founder of Instagram; Arash Ferdowsi, Co-Founder of Dropbox and many others. | $300K / Seed / May 26, 2021 | |
Evry Health
|
Evry Health makes healthcare affordable and high quality again by providing expanded benefits at an affordable price. The company is responding to the need to make healthcare affordable and accessible again. Evry Health is based in Mountain View, California and was founded in 2017. | $50K / Series A / May 14, 2021 | |
Newzip
|
Newzip is an online marketplace that helps users connect to local experts to answer questions about a neighborhood. | $50K / Seed / May 14, 2021 | |
|
Betterhalf
|
Uniquely positioned as a new age matrimony platform, Betterhalf envisions to build a super app of Indian matrimony and full stack wedding services as company's growth pillars. Founded by Pawan Gupta and Rahul Namdev, Betterhalf recently raised Series A backed by FinSight Ventures (Ex Bumble investor) & other marquee investors includingMike Krieger, Co-founder of Instagram; Arash Ferdowsi, Co-Founder of Dropbox and many others. | $50K / Seed / Apr 21, 2021 | |
Prenda
|
Prenda is an ed-tech company with the vision of helping young people learn technology in fun informal settings. It helps libraries and schools run code clubs weekly meetings where people work together to teach themselves computer programming. The company was founded in 2015 and is headquartered in Mesa, Arizona. | $19.2M / Series B / Apr 12, 2021 | |
Lalabox
|
Lalabox is a mobile application that offers live-streaming and shopping services. It offers an online platform that allows users to watch, stream, and share videos, while buying and selling various products. Lalabox was founded in 2020 by Kirill Avery and Yurii Yatsenko. | $2M / Seed / Mar 25, 2021 | |
Forcyte Biotechnologies
|
Forcyte Biotechnologies, Inc. was formed to leverage FLECS Technology (originally developed in the Di Carlo Lab @ UCLA) to provide drug-makers and researchers direct access to cellular force generation at the single-cell level – a cellular behavior that was previously inaccessible in an automated way.Forcyte Biotechnologies provide a fundamentallynew class of cell-based assays that functionally evaluate single-cell contractility, integrated into standard multi-wellplate vessels – available both as end-to-end services, and as consumables. | $25K / Seed / Mar 25, 2021 | |
| See all 36 investments → | |||
Co-Investors
Y Combinator
8 deals together
Pioneer Fund
4 deals together
Alumni Ventures
3 deals together
Acequia Capital (AceCap)
2 deals together
Kleiner Perkins
2 deals together
Manhattan Venture Partners (MVP)
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Daniel Schryer invest in?
Daniel Schryer invests primarily in Software, Internet and Mobile startups, most often at Seed and Series B stage. Most of the 36 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Daniel Schryer's check size?
Daniel Schryer typically joins rounds of $25k–$1M at Seed, $75k–$670k at Angel and $150k–$50M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Daniel Schryer participates in.
When did Daniel Schryer last invest?
The most recent investment recorded for Daniel Schryer closed in Jul 2021. Shizune tracks 36 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
